On January 4, 2016, Fredric N. Eshelman has given an investor presentation to shareholders of Puma Biotechnology, Inc. in connection with its consent solicitation. In addition, Fredric N. Eshelman wrote a letter to shareholders of the Company asking their support in adding 4 additional members to the current 5 member Board of the Company.